30–50 nm Precision Nanoarchitecture
Our proprietary framework maintains a tight particle size distribution between 30–50 nm to optimize tissue penetration and cellular uptake while minimizing off-target toxicity.
Next-Generation Lipid Nanoparticle Platforms
Advancing precision drug delivery through rational nanoengineering and scalable process innovation.
Our Vision
Expanding the Boundaires of
Therapeutic Reach
Hermez Nanomedicine is advancing a precision-engineered, clinically scalable delivery architecture designed to redefine how medicines are translated from molecular discovery to global deployment.
Precision LNP Engineering & One-Pot Synthesis
Technology Platform
Hermez is dedicated to advancing precision medicine through rational nanoengineering and scalable process innovation, overcoming biological barriers to ensure drug delivery excellence.
Translating High-Potential Therapeutics
Applications
Our platform transforms delivery-constrained candidates into clinically actionable programs, supporting a wide range of drug modalities.
Oncology
Improving tissue permeability and reducing dose-limiting toxicity.
Metabolic Diseases
Precision-engineered targeting for systemic metabolic regulation.
Translating High-Potential Therapeutics
Applications
Our platform transforms delivery-constrained candidates into clinically actionable programs, supporting a wide range of drug modalities.
Oncology
Improving tissue permeability and reducing dose-limiting toxicity.
Metabolic Diseases
Precision-engineered targeting for systemic metabolic regulation.